This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Canadian Blood Services. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Vinayakumar Siragam: Innovator in Autoimmune Disease Treatment
Introduction
Vinayakumar Siragam is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. His innovative approach focuses on cell-based therapy, which has the potential to change the landscape of autoimmune disease management.
Latest Patents
Vinayakumar holds a patent for a method titled "Method for treating autoimmune diseases and compositions therefor." This patent describes a method of cell-based therapy aimed at stimulating leukocytes and/or dendritic cells to interrupt autoimmunity in a host. The method utilizes a Fcγ receptor-specific complex or a complex that results in the co-crosslinking of Fcγ-chains to treat leukocytes and/or dendritic cells. Upon reintroducing the pre-treated biological sample to the patient, the dendritic cells elicit an autoimmune interruption response in vivo. This innovative method represents a significant advancement in the treatment of autoimmune conditions.
Career Highlights
Throughout his career, Vinayakumar has worked with reputable organizations, including Canadian Blood Services and Alan H. Lazarus. His experience in these institutions has allowed him to develop and refine his innovative approaches to medical treatment.
Collaborations
Vinayakumar has collaborated with notable professionals in his field, including Alan H. Lazarus and Davor Brinc. These collaborations have contributed to the advancement of his research and the development of his patented methods.
Conclusion
Vinayakumar Siragam is a pioneering inventor whose work in autoimmune disease treatment showcases the potential of innovative medical therapies. His contributions are paving the way for new approaches to managing autoimmune conditions, ultimately benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
